Ifosfamide and Peripheral sensorimotor neuropathy - a phase IV clinical study of FDA data

Summary:

Peripheral sensorimotor neuropathy is reported as a side effect among people who take Ifosfamide (ifosfamide), especially for people who are male, 2-9 old, have been taking the drug for 1 - 6 months also take Bactrim, and have Sarcoma.

The phase IV clinical study analyzes which people have Peripheral sensorimotor neuropathy when taking Ifosfamide. It is created by eHealthMe based on reports of 21,274 people who have side effects when taking Ifosfamide from the FDA, and is updated regularly.

What is Ifosfamide?

Ifosfamide has active ingredients of ifosfamide. eHealthMe is studying from 21,285 Ifosfamide users. Check the latest studies of Ifosfamide.

What is Peripheral sensorimotor neuropathy?

Peripheral sensorimotor neuropathy (damage to one or more of your peripheral nerves) is found to be associated with 185 drugs and 322 conditions by eHealthMe. Check the latest studies of Peripheral sensorimotor neuropathy.

On Jul, 23, 2026

21,274 people reported to have side effects when taking Ifosfamide.
Among them, 21 people (0.1%) have Peripheral sensorimotor neuropathy.

Could Ifosfamide cause Peripheral sensorimotor neuropathy?

Among these 21 people:

How long have people been on Ifosfamide when they have Peripheral sensorimotor neuropathy? *

What is the gender of people who have Peripheral sensorimotor neuropathy when taking Ifosfamide? *

female: 15 %
male: 85 %

What is the age of people who have Peripheral sensorimotor neuropathy when taking Ifosfamide? *

What are other drugs people take besides Ifosfamide? *

Bactrim: 17 people, 80.95%
Cernevit-12: 13 people, 61.90%
Neurontin: 4 people, 19.05%
Dactinomycin: 4 people, 19.05%
Zofran: 3 people, 14.29%
Clonazepam: 3 people, 14.29%
Fentanyl: 3 people, 14.29%
Acetaminophen: 3 people, 14.29%
Omeprazole: 3 people, 14.29%
Piperacillin And Tazobactam: 3 people, 14.29%

What are other side effects people have besides Peripheral sensorimotor neuropathy? *

Mucosal Inflammation (infection of mucous membrane): 17 people, 80.95%
Febrile Bone Marrow Aplasia (bone marrow greatly decreases or stops production of blood cells): 17 people, 80.95%
Neuralgia (pain in one or more nerves): 17 people, 80.95%
Erythema Multiforme (a type of hypersensitivity reaction): 14 people, 66.67%
Rash Vesicular (rash with a small bubble): 10 people, 47.62%
Herpes Zoster: 2 people, 9.52%
Joint Pain: 2 people, 9.52%
Drug Ineffective: 1 person, 4.76%
Febrile Neutropenia (fever with reduced white blood cells): 1 person, 4.76%
Fatigue (feeling of tiredness): 1 person, 4.76%

What are the existing conditions these people have? *

Sarcoma (rare cancers that develop in the muscle, bone, nerves, cartilage, tendons, blood vessels and the fatty and fibrous tissues): 17 people, 80.95%
Hodgkin's Lymphoma (cancer originating from white blood cells): 3 people, 14.29%
Burkitt's Lymphoma (cancer of the lymphatic system): 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Ifosfamide and have Peripheral sensorimotor neuropathy?

- Check whether Peripheral sensorimotor neuropathy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ifosfamide:

Ifosfamide (21,285 reports)

Browse all side effects of Ifosfamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Peripheral sensorimotor neuropathy:

Peripheral sensorimotor neuropathy (185 drugs)

Browse all the conditions that are associated with Peripheral sensorimotor neuropathy:

Peripheral sensorimotor neuropathy (322 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ifosfamide (the active ingredients of Ifosfamide) and Ifosfamide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.